What the public record gives you
01Vendor materials, current public documentation, and published methodology notes. We describe each platform with the scope its own current materials claim, and label that provenance plainly when we do.
About Sudova Agent
Sudova Agent is a clinical trial technology resource based in Cambridge, Massachusetts. We write for sponsors, clinical operations leads, and study teams in the United States comparing RTSM/IRT platforms and the eClinical systems around them.
Why this site exists
Platform decisions in clinical trials get made with less public information than the stakes deserve.
Vendor pages describe products favorably. Buyers trade notes privately. A study team can spend weeks assembling a picture a single well-organized resource could have provided. Sudova Agent is an attempt at that resource, focused on RTSM and the systems around it rather than on clinical research broadly.
What the public record gives you
01Vendor materials, current public documentation, and published methodology notes. We describe each platform with the scope its own current materials claim, and label that provenance plainly when we do.
What a private buyer network gives you
02Direct experience of study teams who have run the platform. Useful, but trading notes privately means the same conversations restart in another company the next quarter.
What this resource adds
03Criteria written down before any comparison, published in the same place for every platform, and revised when the market consolidates rather than when a vendor asks.
The reader runs or supports a trial and has to make a technology call. We assume working knowledge of trial conduct and no patience for vendor language.
Operations managers comparing IRT vendors across studies, and leads deciding mid-study whether a platform can absorb a protocol amendment without rebuilding supply rules from scratch.
Vendor comparison
Scope, service model, and the mid-study change handling a vendor will describe on a call. Reading it before the call changes what you ask.
Integration load
Which adjacent system brings its own connectors and which one hands you a spreadsheet. This is where a suite and a focused provider diverge first.
Data management
Data managers weighing how much of the trial record one vendor already owns, and whether adding another platform means adding another reconciliation queue.
Sponsor procurement
Sponsor teams deciding whether a suite or a focused provider fits, and what that choice means for who owns the trial record three years from now.
Where a term needs explaining, we explain it once and move on. That includes RTSM itself, IRT, and the difference between randomization and trial supply management, which we treat as separate skills because they are.
Randomization and trial supply management sit at the center of this site, because in a live study they are the systems a protocol change touches first.
Randomization Arm assignment and IWRS scheduling The point where a protocol change reaches the supply chain Supply Depots, shipments, kit release Where a shipment window closes and a resupply decision opens Vendors IQVIA, Medidata, Medrio, Suvoda, Signant, YPrime Each described with the scope its current materials claimEDC, CTMS, eCOA, ePRO, eConsent, and eTMF appear in the platform bundles sponsors actually evaluate, so we cover them the same way.
EDC Electronic data capture The clinical record most integrations are reconciled back into CTMS Trial management vantage Where a sponsor sees study progress without opening the RTSM eCOA & ePRO Participant-facing capture Diary and outcome collection where the participant, not the site, is the user eConsent & eTMF Consent flow and document control Two systems where a signature or a filing closes a chain of custodyWhat we are not
This site is not a vendor, an advisory firm, or a source of pricing, and nothing here should be read as a compliance opinion. If you need a platform recommendation tied to a live protocol, that work belongs with your quality and clinical teams, using what you find here as input.
Scope boundary
What to do instead
Take the criteria and the platform notes to a live protocol review with the team that will own the system. Ask them to run a mid-study change scenario end to end.
Send a correction
We do not sell platforms and do not accept payment for placement. Comparisons are organized around five criteria, and the reasoning behind them is published on the evaluation method page.
Criteria
Where we are
Sudova Agent operates from 1201 Innovation Drive, Suite 300, Cambridge, MA 02142. Cambridge puts us inside a dense clinical research corridor, though the site's audience is national.